Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients Within the Veneto Oncology Network: the ROVID Study

The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network

The aim of this study is to create a Veneto Oncology Network with the aim of collecting clinical and epidemiological data of cancer Patients affected by SAR- Covid-2 infection over a period of 1 year. Descriptive statistical approaches will be used to process the data.

The aim is to evaluate the development rate of severe clinical forms of infection in patients with SARS-Cov-2 and the possible association with tumour characteristics and treatment.

In addition, the results of serological tests can be compared with the outcome of the diagnostic swabs and the clinical evolution of the infection in order to obtain more information regarding the significance of specific antibody development.

Inclusion Criteria:

• be 18 Years and older
• cancer patients belonging to Veneto 's Oncological Network
• Patients with SAR COV-2 infection

Exclusion Criteria:

• Patients with no SAR COV2 Infection
• Volunteers
• No Cancer Patients